What is it about?
In a period of two years, willingness to participate in HIV vaccine studies was evaluated among behavioural vulnerable young people. Willingness to participate in future HIV trials was high at the beginning and at the end. Being young and wanting to contribute to the fight against HIV was associated with wanting to participate in experimental vaccine studies.
Featured Image
Photo by Jon Tyson on Unsplash
Why is it important?
Our study reinforces the practicality of conducting HIV vaccine trials in Maputo. It contributed with knowledge that can be leveraged for the development of communication and retention strategies of future HIV vaccine clinical trials to be conducted in Mozambique.
Perspectives
Read the Original
This page is a summary of: Young at risk-people in Maputo City, Mozambique, present a high willingness to participate in HIV trials: Results from an HIV vaccine preparedness cohort study, PLoS ONE, December 2021, PLOS,
DOI: 10.1371/journal.pone.0260126.
You can read the full text:
Contributors
The following have contributed to this page